DAB2IP and hepatocellular carcinoma: tRF‐34‐P4R8YP9LON4VHM Regulates the MEK/ERK Pathway by Silencing DAB2IP Expression in HCC Cells and Drives Tumour Cell‐Induced Angiogenesis by Secreting VEGFA